BLUE sells—(upsized)—4.38M* shares @$105.00—a 5.5% discount to yesterday’s close, raising $432M* in net proceeds: https://finance.yahoo.com/news/bluebird-bio-announces-pricing-public-222900413.html *Assuming exercise of underwriter’s option; assuming standard 6% underwriter’s fee.